

The hearing deficit is usually temporary.

The use of Otomax ointment has been associated with deafness or partial hearing loss in a smallnumber of sensitive dogs (eg, geriatric). Do not usein dogs with known perforation of eardrums. Concomitant use of drugs known to induce ototoxicity should be avoided. If hypersensitivity to any of the components occurs, treatment should be discontinued and appropriatetherapy instituted. In patients presently receiving or recently withdrawn from corticosteroid treatments, therapy with a rapidly-acting corticosteroid should beconsidered in especially stressful situations.īefore instilling any medication into the ear, examine the external ear canal thoroughly to be certain thetympanic membrane is not ruptured in order to avoid the possibility of transmitting infection to themiddle ear as well as damaging the cochlea or vestibular apparatus from prolonged contact. Use of corticosteroids, depending on dose, duration, and specific steroid, may result in endogenoussteroid production inhibition following drug withdrawal. Prolonged use or overdosage may produce adverse immunosuppressive effects. Patients should be closely observed for the usual signs of adrenocorticoid overdosage which include sodium retention, potassium loss, fluid retention, weightgain, polydipsia, and/or polyuria. Adverse systemic reactions have been observed following the oral ingestion of some topical corticosteroid preparations.

If overgrowth of nonsusceptible bacteria, fungi, or yeasts occur, or if hypersensitivity develops,treatment should be discontinued and appropriate therapy instituted.Īdministration of recommended doses of Otomax ointment beyond 7 days may result in delayed wound healing.Īvoid ingestion. Antibiotic susceptibility of the pathogenic organism(s) should be determined prior to use of this preparation. Identification of infecting organisms should be made either by microscopic roll smear evaluation or byculture as appropriate. Keep this and all drugs out of the reach of children. Caution:įederal law restricts this drug to use by or on the order of a licensed veterinarian. Therapy should continue for 7 consecutive days. Instill 8 drops from the 7.5 g and 15 g tube, and 15 g and 30g bottle (4 drops from the 215 g bottle) twice daily into the ear canal of dogs weighing 30 lbs or more.Massage external ear canal carefully after instillation to ensure appropriate distribution of medication. After verifying that the eardrum is intact, instill 4 drops from the 7.5 g and 15 gtube, and 15 g and 30 g bottle (2 drops from the 215 g bottle) of Otomax ointment twice daily into theear canal of dogs weighing less than 30 lbs. Excessive hair should be clippedfrom the treatment area. Remove foreign material,debris, crusted exudates, etc., with suitable nonirritating solutions. The external ear should be thoroughly cleaned and dried before treatment. Otomax Ointment is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co.

Gentamicin is an antibiotic with broad spectrum activity.Otomax Otic Ointment is indicated for the treatment of canine acute and chronic otitis externa associated with yeast ( Malassezia pachydermatis) and/or bacteria susceptible to gentamicin. Easy to administer has the consistency of a solution with the prolonged contact time of an ointmentīy virtue of its three active ingredients Gentamicin, Betamethasone, and Clotrimazole, Otomax ointment provides antibacterial, anti-inflammatory, and antifungal activity to combat infections of the outer ear accompanied by inflammation.Treats both acute and chronic ear infections.It is a combination steroid, antibacterial, and antifungal ear medication labeled for use in dogs. Otomax is an ointment used to treat ear infections.
